Key result
Imipramine causes a ~26 mmHg systolic postural drop vs doxepin and placebo in geriatric outpatients.
Why the study?
Does imipramine or doxepin increase orthostatic hypotension compared to placebo in depressed geriatric outpatients?
RCT (n=36)
Double-blind
Does imipramine or doxepin increase orthostatic hypotension compared to placebo in depressed geriatric outpatients?
Imipramine causes significantly greater orthostatic hypotension compared to doxepin and placebo in depressed geriatric outpatients, warranting caution in its use.
Answers are grounded in this paper and cite their sources.
Clinicians should avoid imipramine in favor of doxepin for geriatric depression to reduce orthostatic risk; reinforces differential TCA effects in RCTs.
Blood pressure measurements were collected from 36 depressed geriatric outpatients (ages 55 to 81 years) enrolled in a double-blind, placebo-controlled study of the efficacy of doxepin and imipramine. Mean systolic postural changes were 25.9 mm Hg for imipramine, significantly higher than the 10.5 mm Hg for doxepin, and 12.4 mm Hg for placebo. The orthostatic drop in the imipramine group was only weakly related to dose and did not correlate with amount of pretreatment orthostatic hypotension or with duration of treatment. The increased orthostatic hypotension occurred early in treatment and at low doses of imipramine. Accordingly, caution is advised in the use of imipramine for the elderly.
No takes yet. Share an insight, caveat, or question.
Neshkes et al. (1985) conducted an RCT in Depression (n=36). Imipramine and doxepin vs. Placebo was evaluated on Mean systolic postural changes. Imipramine caused a higher mean systolic postural drop compared to doxepin and placebo in depressed geriatric outpatients.
Synapse has enriched 10 related papers. Consider them for comparative context: